Clinipace appoints Bud Owen and Daryl Porter
pharmafile | February 19, 2010 | Appointment | Research and Development | Clinipace, appointment, research and development
CRO and eClinical technology specialist Clinipace Worldwide has appointed Bud Owen as its chief financial officer, while Daryl Porter has joined the company as chief technology officer.
Owen will lead the accounting, treasury, and tax group and be a key member of Clinipace’s mergers and acquisitions team.
He initially joined Clinipace as an advisor during the recent acquisition of Worldwide Clinical Research.
Prior to joining Clinipace, Owen served as chief financial officer at a number of large and small companies in the software, web services, and manufacturing industries, including MediaSpan Group, Reichhold Chemicals, and Tables Surfaces, a company he co-founded.
Meanwhile Porter will lead the service engineering, product engineering, and cloud computing infrastructure teams.
Prior to joining Clinipace Worldwide, Porter spent 18 years at Oracle Corporation and held several executive-level positions in both enterprise product development and enterprise support services.
Related Content
Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …
Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …
Lonza CEO to step down in 2020
It has been announced that Marc Funk, Chief Executive Officer at Lonza, is set to …